3 Beaten-Up Biotechs Bouncing Back in 2017 (Hint: One Is a Marijuana Stock)

Not every stock that falls on tough times is worth buying in portfolios, but sometimes, catalysts can spark shareholder-friendly rallies, and in those situations, it can make sense. For example, risk-tolerant investors might want to consider picking up shares in the beaten-up biotech stocks Zogenix (NASDAQ: ZGNX), Insys Therapeutics (NASDAQ: INSY), and Keryx Pharmaceuticals (NASDAQ: KERX). All three of these stocks are former highfliers, and each has catalysts that could help them regain some of their former glory.

Zogenix's share price has been more than cut in half from its peak in 2014, but a lot of those losses could be gained back if data that's expected this fall on its lead drug candidate is good.

IMAGE SOURCE: GETTY IMAGES.

Continue reading

Source: Fool.com